AZ and BMS job cuts add to big pharma woes
As pharma firms disclose their financial results for the second quarter of the year, AstraZeneca (AZ) and Bristol-Myers Squibb (BMS) have announced more job cuts.
As pharma firms disclose their financial results for the second quarter of the year, AstraZeneca (AZ) and Bristol-Myers Squibb (BMS) have announced more job cuts.
The total contract research organisation (CRO) market is expected to reach $24bn (€18bn) by 2010 as biopharma companies' spending on outsourcing services continues to soar, new research reveals.
Indian biotech heavyweight Biocon has today announced that its joint venture with Abu Dhabi-based Neopharma has spawned new company NeoBiocon, operating out of one of Dubai's newest biotechnology parks.
Weekly comment
The UK government has been ordered to review the assessment system it uses to classify and grant permission for animal experiments following a court ruling handed down last week.
PRA said it signed an agreement with equity firm Genstar Capital to be bought back by the firm for around $790m (€580m) while the CRO posted a 90 per cent tumble in profit in Q2 due to heavy restructuring charges.
A novel drug delivery technology capable of delivering large molecules in oral tablet form is set to gain patent protection in a number of countries through an international patent treaty.
Aperio has released a new software tool that not only speeds up the analysis of tissue microarray (TMA) images but also allows researchers to access images remotely.